And, primarily because of the daunting scientific obstacles, woefully few companies have an aggressive AIDS-vaccine program.
271740
Primarily because of the scientific challenges, few companies invest in AIDS vaccine programs.
271741
Companies have been readily investing in AIDS vaccine research.